Hovione Technology is a privately funded company dedicated to the development and commercialization of inhalation devices. We make and supply innovative and attractive inhalation devices to the global market that maximize simplicity of use, safety, drug delivery performance and cost effectiveness.

We rely on 20 years of experience in inhalation device development and inhalation market knowledge. Our team joins experienced top managers, business entrepreneurs and skilled engineers with a track record for developing and supplying novel and effective dry powder inhalation devices that have been successfully market launched.

Hovione Technology’s mission is to offer simple, multipurpose, easy to use, globally competitive inhalation delivery devices.

We value integrity, family, creativity and passion to deliver as promised. These core values spin-off from our managers’ experience who have successfully built a 55 year-old sustainable and leading pharmaceutical group of companies, the Hovione Industrial Group.

Hovione Technology firmly believes in the value added and benefits for the patient provided by its family of unique inhalation devices covering both acute and chronic treatments. Consequently, we follow a mid/long term strategy and promote stable relationships with our counterparts – pharmaceutical and device manufacturing business partners – sharing the goal of offering simple, easy to use and effective inhalation devices to the patient.